FRM1R - Rigas farmaceitiska fabrika

Pagrindiniai finansiniai rodikliai (LVL)

Kaina	P/BV	P/E	P/S	GPM,%	Grynasis pelnas, M	Akcijų sk.
0.78 LVL	0.35	85.20	1.42	3.02	0.01	663 000

Kap., M	Pardavimai, M	EPS	Buhalterinė vertė	Pardavimai akcijai	EBIT, M	EBITDA, M
0.52	0.37	0.01	2.25	0.55	0.11	0.15

EV, M	EV/EBIT	EV/EBITDA	ROE	ROA	Grynoji skola, M
0.87	7.93	5.94	0.00	0.00	-0.11

Paskutinė ataskaita

http://www.nasdaqomxbaltic.com/market/?pg=reports

Naujienos

2010-06-15 16:37 FRM: AS RFF 6 months 2010 year financial report

2010-04-28 14:49 FRM: Action plan for the year 2010

2010-04-14 10:17 FRM: Draft decisions of Shareholders Meeting

2010-03-29 15:20 FRM: CORRECTION: Announcement of Shareholders Meeting

2010-03-24 15:07 FRM: On the submission of AS RFF financial report for 2010 year 1 quarter

2010-03-01 10:24 FRM: JSC RFF 2009 year financial statement

2009-12-22 14:11 FRM: On the submission date of AS RFF financial report for 2009 year

2009-11-30 12:12 FRM: AS RFF 2009. year 1-3 quarter financial statement

2009-09-29 16:14 FRM: On new council members CVs

2009-09-29 10:06 FRM: Adopted decisions of Extraordinary Shareholders Meeting of JSC RFF on September 28, 2009

Informacija apie įmonę

Name: AS "Rīgas farmaceitiskā fabrika" Core business: Pharmaceuticals Auditor: SIA "Konsults" Date of listing: 09.11.1998. (Free list); from 21.05.2007 Baltic Secondary List Contacts: Address: Duntes 16/22, Rīga, LV 1005, Latvija Phone: + 371 67355550 Fax: + 371 67355551, 67391790 Internet: www.rff.lv Contactperson: Kaspars Bāliņš Phone: + 371 67355550 Fax: + 371 67355551, 67391790 E-mail: kaspars@rff.lv

Vadovybė

Vladimirs Ivanikins	Member of the Supervisory Board
Jūlija Dmitrijeva	Member of the Supervisory Board
Aleksandrs Livšics	Member of the Supervisory Board
Vadims Telica	Member of the Supervisory Board
Dailonis Pakalns	Member of the Supervisory Board
Uģis Freimanis	Member of the Board
Vladimirs Rukavicins	Member of the Board
Kaspars Bāliņš	Chairman of the Board

Pagrindiniai akcininkai

Bergere Irina	36.48% (0.24 M)
Livšics Aleksandrs	32.86% (0.22 M)
Oskerko Jānis	9.09% (0.06 M)
Kiti akcininkai	21,57% (0.14 M)